{"code":"Q2041","short_description":"Axicabtagene ciloleucel car+","long_description":"Axicabtagene ciloleucel, up to 200 million autologous anti-cd19 car positive viable t cells, including leukapheresis and dose preparation procedures, per therapeutic dose","status":"active","section":"Q-codes: Temporary Codes","category":"Temporary","effective_date":"2019-01-01","termination_date":null,"replacement_code":"","opps_status_indicator":"K","opps_status_label":"Non-pass-through drugs and biologicals","opps_apc":"9035","fee_schedules":[],"mue":[],"drug_classes":[],"ndc_crosswalk":[{"ndc":"71287-0119-01","drug_name":"Yescarta","dosage":"UP TO 200 million CAR T cells","unit":"1","labeler_name":"Gilead Sciences, Inc."}],"utilization":[],"urls":{"self_html":"https:\/\/hcpcslookup.com\/codes\/q2041","self_json":"https:\/\/hcpcslookup.com\/api\/codes\/Q2041.json"}}